Literature DB >> 23389443

Corrigendum: Comprehensive genomic characterization defines human glioblastoma genes and core pathways.

The Cancer Genome Atlas Research Network.   

Abstract

Entities:  

Year:  2013        PMID： 23389443     DOI： 10.1038/nature11903

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  2 in total

1.  Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2.

Authors:  Heidi Greulich; Bethany Kaplan; Philipp Mertins; Tzu-Hsiu Chen; Kumiko E Tanaka; Cai-Hong Yun; Xiaohong Zhang; Se-Hoon Lee; Jeonghee Cho; Lauren Ambrogio; Rachel Liao; Marcin Imielinski; Shantanu Banerji; Alice H Berger; Michael S Lawrence; Jinghui Zhang; Nam H Pho; Sarah R Walker; Wendy Winckler; Gad Getz; David Frank; William C Hahn; Michael J Eck; D R Mani; Jacob D Jaffe; Steven A Carr; Kwok-Kin Wong; Matthew Meyerson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

2.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways.

Authors: 
Journal:  Nature       Date:  2008-09-04       Impact factor: 49.962
  2 in total
  57 in total

1.  Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.

Authors:  Jia Wang; Peng Cheng; Marat S Pavlyukov; Hai Yu; Zhuo Zhang; Sung-Hak Kim; Mutsuko Minata; Ahmed Mohyeldin; Wanfu Xie; Dongquan Chen; Violaine Goidts; Brendan Frett; Wenhao Hu; Hongyu Li; Yong Jae Shin; Yeri Lee; Do-Hyun Nam; Harley I Kornblum; Maode Wang; Ichiro Nakano
Journal:  J Clin Invest       Date:  2017-07-24       Impact factor: 14.808

2.  Next-generation sequencing is a robust strategy for the high-throughput detection of zygosity in transgenic maize.

Authors:  Leonie Fritsch; Rainer Fischer; Christoph Wambach; Max Dudek; Stefan Schillberg; Florian Schröper
Journal:  Transgenic Res       Date:  2015-02-04       Impact factor: 2.788

3.  Overexpression of centrosomal protein 55 regulates the proliferation of glioma cell and mediates proliferation promoted by EGFRvIII in glioblastoma U251 cells.

Authors:  Hongfan Zhu; Diangang Chen; Jinliang Tang; Changlin Huang; Shengqing Lv; Donglin Wang; Guanghui Li
Journal:  Oncol Lett       Date:  2017-12-08       Impact factor: 2.967

4.  Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients.

Authors:  Deborah T Blumenthal; Addie Dvir; Alexander Lossos; Tzahala Tzuk-Shina; Tzach Lior; Dror Limon; Shlomit Yust-Katz; Alejandro Lokiec; Zvi Ram; Jeffrey S Ross; Siraj M Ali; Roi Yair; Lior Soussan-Gutman; Felix Bokstein
Journal:  J Neurooncol       Date:  2016-08-16       Impact factor: 4.130

Review 5.  Co-inhibitory blockade while preserving tolerance: checkpoint inhibitors for glioblastoma.

Authors:  Liliana E Lucca; David A Hafler
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

Review 6.  Integrative approaches for finding modular structure in biological networks.

Authors:  Koyel Mitra; Anne-Ruxandra Carvunis; Sanath Kumar Ramesh; Trey Ideker
Journal:  Nat Rev Genet       Date:  2013-10       Impact factor: 53.242

7.  The Long Non-coding RNA HIF1A-AS2 Facilitates the Maintenance of Mesenchymal Glioblastoma Stem-like Cells in Hypoxic Niches.

Authors:  Marco Mineo; Franz Ricklefs; Arun K Rooj; Shawn M Lyons; Pavel Ivanov; Khairul I Ansari; Ichiro Nakano; E Antonio Chiocca; Jakub Godlewski; Agnieszka Bronisz
Journal:  Cell Rep       Date:  2016-06-02       Impact factor: 9.423

Review 8.  The Mechanism of Asparagine Endopeptidase in the Progression of Malignant Tumors: A Review.

Authors:  Wenrui Zhang; Yingying Lin
Journal:  Cells       Date:  2021-05-10       Impact factor: 6.600

Review 9.  Combining Radiation Therapy with ALK Inhibitors in Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer (NSCLC): A Clinical and Preclinical Overview.

Authors:  Delphine Antoni; Hélène Burckel; Georges Noel
Journal:  Cancers (Basel)       Date:  2021-05-15       Impact factor: 6.639

10.  Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance.

Authors:  Wei Wu; Jessica L Klockow; Michael Zhang; Famyrah Lafortune; Edwin Chang; Linchun Jin; Yang Wu; Heike E Daldrup-Link
Journal:  Pharmacol Res       Date:  2021-07-21       Impact factor: 10.334
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.